ROSEN, A Leading Law Firm, Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Act Before January 2 Deadline in Relation to Securities Class Action
Dec 24, 2023
Brainstorm Invest Advisor
ROSEN LAW FIRM Reminds Brainstorm Cell Therapeutics Investors of Key Class Action Deadline
Nov 27, 2023